Stay updated on Seladelpar in PBC Subjects Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.

Latest updates to the Seladelpar in PBC Subjects Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.6.0 to v3.6.2 in the page footer, indicating a new build of the ClinicalTrials.gov interface rather than substantive changes to the study record.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated. A recruitment-status note (No longer looking for participants) was added and the revision label indicates an update from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous revision and signaling a minor update to the page version.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a new citation for the ASSURE interim study results (Levy et al., Am J Gastroenterol 2025) to the Publications section and removed the older interim results citation, updating the record to reflect the latest published report.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now lists 109 study locations, including a new site in Saint Petersburg, Russia. The estimated enrollment has changed from 500 to 340.SummaryDifference0.3%

- Check65 days agoChange DetectedClinicalTrials.gov’s page footer “Revision” was updated from v3.5.2 to v3.5.3, reflecting a site version update rather than a change to the study record.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in PBC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.